Effectiveness of Cross K-wire Vs Lateral Entry K-wire Fixation in Maintaining Reduction of Gartland Type 3 Supracondylar Fractures of Children
1 other identifier
interventional
90
1 country
1
Brief Summary
This study compares the efficacy of K wire when inserted in Cross V/s Lateral Direction in Supracondylar fractures of Gartland Type 3 in children. A comparative study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 24, 2025
CompletedFirst Posted
Study publicly available on registry
December 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedDecember 5, 2025
November 1, 2025
1.5 years
November 24, 2025
November 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
frequency of post K wire fixation loss of reduction
It is comonly noted that after lateral K wire fixation there is more frequent loss of reduction as compared to cross fixation method. The frequency of loss of reduction will be noted after the intervention.
2 months
Study Arms (2)
Group A
ACTIVE COMPARATORThe participants enrolled in this arm will be treated with cross K wire fixation
Group B
EXPERIMENTALThe participants enrolled in this arm will be treated with lateral fixation of K wire after supracondylar fracture.
Interventions
In this intervention the K wire will be fixed in a Manner of Cross at the site of frature.
In this arm of intervention the K wire will be fixed laterally at the site of fracture.
Eligibility Criteria
You may qualify if:
- All male and female patients of age 02-13 years with Gartland type 3 Supracondylar Fracture of Humerus less than 7 days old
You may not qualify if:
- patients with open fractures patients with neurovascular injuries patients with medial column communition Fractures more than 7 Days old Ipsilateral fractures of radius/ulna or shaft of humerus pathological fractures which are associated with bone density changes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laiba Qamarlead
- Bahawal Victoria Hospital Bahawalpurcollaborator
Study Sites (1)
Bahawal Victoria Hospital
Bahawalpur, Punjab Province, 16300, Pakistan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 24, 2025
First Posted
December 5, 2025
Study Start
July 1, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
December 5, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share